Awards

$111K

A diagnostic instrument to manage hemostasis in chronic liver disease

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-095
Budget: 09/01/12 - 08/31/13
PI: Francesco Viola

DESCRIPTION (provided by applicant): The clinical evaluation and management of hemostasis in the 5 million patients affected by chronic liver diseases (CLD) is poorly understood. Data presented at two International Symposia on Coagulation in Liver Disease and summarized in a recent edition of Clinics in Liver Disease strongly support the presenc...

$868K

Development of a diagnostic instrument to manage hemostasis in chronic liver dise

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-095
Budget: 09/01/11 - 08/31/12
PI: Francesco Viola

DESCRIPTION (provided by applicant): The clinical evaluation and management of hemostasis in the 5 million patients affected by chronic liver diseases (CLD) is poorly understood. Data presented at two International Symposia on Coagulation in Liver Disease and summarized in a recent edition of Clinics in Liver Disease strongly support the presenc...

$318K

Development of a diagnostic instrument to manage hemostasis in chronic liver dise

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-095
Budget: 09/01/10 - 08/31/11
PI: Francesco Viola

DESCRIPTION (provided by applicant): The clinical evaluation and management of hemostasis in the 5 million patients affected by chronic liver diseases (CLD) is poorly understood. Data presented at two International Symposia on Coagulation in Liver Disease and summarized in a recent edition of Clinics in Liver Disease strongly support the presenc...

$299K

Development of a point of care diagnostic to guide efficient usage of blood produ

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 08/06/10 - 08/05/11
PI: Francesco Viola

DESCRIPTION (provided by applicant): Over 60% of the 600,000 patients undergoing cardio-pulmonary bypass (CPB) procedures in the US each year experience intra- and post-operative bleeding. Treatment options are available, each corresponding to a specific hemostatic defect: (a) fresh frozen plasma (FFP) to correct the plasma coagulation proteins,...

$70K

Miniature, Portable, Device to Detect and Monitor Coagulopathy

Phase 1 STTR

Institution: University of Virginia

Agency: Navy
Topic: N10A-T043
Budget: 06/28/10 - 04/30/11
PI: Francesco Viola

Trauma is a leading cause of both military and civilian mortality, accounting for roughly 10% of all deaths worldwide. Coagulopathy (disturbance of the physiologic balance between bleeding and clotting) is observed in 25% to 36% of trauma patients and significantly increases mortality. Trauma-related coagulopathy typically involves dysfunction o...